launch own cryptocurrency- Top Overview

The liquor sector moved up, Tianyoude Liquor rose daily, Gujing Distillery rose by more than 4%, and Huangtai Liquor, Shunxin Agriculture, Laobaigan Liquor and Yilite followed suit.Actually, Zhijia has set up a new company to sell new energy vehicles. The enterprise search APP shows that recently, Beijing Dongwo Retail Co., Ltd. was established, with the legal representative of Li Jie and the registered capital of 10 million yuan. Its business scope includes: automobile sales; New energy vehicle sales; Wholesale of auto parts; Sales of electrical accessories for new energy vehicles; Sales of power exchange facilities for new energy vehicles. Enterprise investigation shows that the company is indirectly wholly-owned by Juran Zhijia.Hang Seng Science and Technology Index rose to 1%, while Kewang shares rose, with Billie Billie (09626.HK) rising by over 4%, Baidu (09888.HK) rising by 2.8%, Aauto Quicker (01024.HK), Tencent Holdings (00700.HK) rising by 1.8% and Alibaba (09988.HK) rising by over 1%.

Backbone Technology: The holding subsidiary recently signed a strategic cooperation agreement on intelligent robots. Backbone Technology (002779) said on the interactive platform on December 12 that recently, Jiangsu Jianmi, the holding subsidiary of the company, signed strategic cooperation agreements with Dongsheng Zhilian and Nanjing Ji Rong respectively, working together to develop and apply automation, visualization and intelligent robots, and promoting the application and development of intelligent technologies in a wider range of fields. Jiangsu Jianmi's Lingrui P1 quadruped robot dog can be used for industrial park management, fire control and public security, daily inspection of power grid and electric power, and inspection of special operation scenes such as smelting enterprises and hazardous chemicals.Trump said that he chose Kari Lake as the director of VOA.Ping An Securities: The gold price center is expected to increase in 2025. Ping An Securities released the 2025 annual strategy report of nonferrous metals and new materials industry, saying that nonferrous metals have entered a stage of high fluctuation in 2024, and the main pricing lines and core variables have changed to varying degrees. 2025 is still a year in which the core contradictions of various varieties continue to ferment, and the monetary attributes of precious metals represented by gold are expected to continue to be prominent. It is expected that the gold price center will still improve throughout the year, and it is recommended to pay attention to Shandong gold and Zhongjin gold; The long-term resource bottleneck of industrial metal copper has bottomed out, and the demand elasticity driven by internal and external policies is expected to be gradually released. It is suggested to pay attention to Zijin Mining and Luoyang Molybdenum Industry; The supply and demand pattern of electrolytic aluminum continues to improve, and the demand side maintains a high growth rate under the shrinking supply elasticity, and the long-term center of aluminum price is expected to further rise. It is recommended to pay attention to Tianshan Aluminum, China Aluminum, Shenhuo and Yunnan Aluminum. Tin resources are in short supply or accelerated transmission, and the gap between supply and demand is further enlarged. It is suggested to pay attention to tin industry shares; At the bottom of the energy metal industry, it is confirmed that enterprises with lower valuation level may enjoy greater flexibility under the marginal improvement of fundamentals. It is recommended to pay attention to enterprises with significant integration advantages, and it is recommended to pay attention to China Mining Resources, Tianqi Lithium Industry and Huayou Cobalt Industry.

Supreme Law: If the heir abandons the decedent, he shall lose the right of inheritance. On December 12th, the Supreme People's Court released the typical cases of inheritance disputes (the second batch). In case 4, Gao Moujia and Gao Xiaomou are related to each other, and Gao Xiaomou is an only child. In 1992, Gao Xiaomou (at the age of 20) left home after a dispute with his parents, and he never cared about his parents. Mother didn't take care of her when she was ill, and she didn't go to her funeral when she died. When Gao Moujia was seriously ill, he needed transportation, nursing and care for major surgery, but Gao Xiaomou did not appear. After Gao Moujia died, Gao Xiaomou ignored the burial of his ashes, but as the only legal heir, he received some bank deposit certificates under Gao Moujia's name. According to the Supreme Law, the people's court ruled that his behavior constituted abandonment according to law and sentenced him to lose the right of inheritance, which demonstrated the positive guidance of the law to social values, was conducive to carrying forward the traditional virtues of filial piety and respect for the elderly of the Chinese nation, and improved the mechanism for giving play to the role of family education and family style construction in grassroots governance.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.